508 related articles for article (PubMed ID: 35565943)
1. Intestinal Microbiota-Derived Short Chain Fatty Acids in Host Health and Disease.
Cong J; Zhou P; Zhang R
Nutrients; 2022 May; 14(9):. PubMed ID: 35565943
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in the therapeutic application of short-chain fatty acids (SCFAs): An updated review.
Rauf A; Khalil AA; Rahman UU; Khalid A; Naz S; Shariati MA; Rebezov M; Urtecho EZ; de Albuquerque RDDG; Anwar S; Alamri A; Saini RK; Rengasamy KRR
Crit Rev Food Sci Nutr; 2022; 62(22):6034-6054. PubMed ID: 33703960
[TBL] [Abstract][Full Text] [Related]
3. Gut bacterial metabolites of indigestible polysaccharides in intestinal fermentation as mediators of public health.
Hijova E
Bratisl Lek Listy; 2019; 120(11):807-812. PubMed ID: 31747759
[TBL] [Abstract][Full Text] [Related]
4. Microbial Regulation of Host Physiology by Short-chain Fatty Acids.
van der Hee B; Wells JM
Trends Microbiol; 2021 Aug; 29(8):700-712. PubMed ID: 33674141
[TBL] [Abstract][Full Text] [Related]
5. Short chain fatty acids: Microbial metabolites for gut-brain axis signalling.
O'Riordan KJ; Collins MK; Moloney GM; Knox EG; Aburto MR; Fülling C; Morley SJ; Clarke G; Schellekens H; Cryan JF
Mol Cell Endocrinol; 2022 Apr; 546():111572. PubMed ID: 35066114
[TBL] [Abstract][Full Text] [Related]
6. Fatty acids produced by the gut microbiota dampen host inflammatory responses by modulating intestinal SUMOylation.
Ezzine C; Loison L; Montbrion N; Bôle-Feysot C; Déchelotte P; Coëffier M; Ribet D
Gut Microbes; 2022; 14(1):2108280. PubMed ID: 35978476
[TBL] [Abstract][Full Text] [Related]
7. Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations.
van de Wouw M; Boehme M; Lyte JM; Wiley N; Strain C; O'Sullivan O; Clarke G; Stanton C; Dinan TG; Cryan JF
J Physiol; 2018 Oct; 596(20):4923-4944. PubMed ID: 30066368
[TBL] [Abstract][Full Text] [Related]
8. The role of short-chain fatty acids in kidney injury induced by gut-derived inflammatory response.
Huang W; Zhou L; Guo H; Xu Y; Xu Y
Metabolism; 2017 Mar; 68():20-30. PubMed ID: 28183450
[TBL] [Abstract][Full Text] [Related]
9. Potential Therapeutic Effects of Short-Chain Fatty Acids on Chronic Pain.
Tang Y; Du J; Wu H; Wang M; Liu S; Tao F
Curr Neuropharmacol; 2024; 22(2):191-203. PubMed ID: 36173071
[TBL] [Abstract][Full Text] [Related]
10. The impact of microbiota-derived short-chain fatty acids on macrophage activities in disease: Mechanisms and therapeutic potentials.
Duan H; Wang L; Huangfu M; Li H
Biomed Pharmacother; 2023 Sep; 165():115276. PubMed ID: 37542852
[TBL] [Abstract][Full Text] [Related]
11. Intracerebroventricular Delivery of Gut-derived Microbial Metabolites in Freely Moving Mice.
Liou CW; Yao TH; Wu WL
J Vis Exp; 2022 Jun; (184):. PubMed ID: 35723471
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs).
Ratajczak W; Rył A; Mizerski A; Walczakiewicz K; Sipak O; Laszczyńska M
Acta Biochim Pol; 2019 Mar; 66(1):1-12. PubMed ID: 30831575
[TBL] [Abstract][Full Text] [Related]
13. Alterations in fecal short chain fatty acids (SCFAs) and branched short-chain fatty acids (BCFAs) in men with benign prostatic hyperplasia (BPH) and metabolic syndrome (MetS).
Ratajczak W; Mizerski A; Rył A; Słojewski M; Sipak O; Piasecka M; Laszczyńska M
Aging (Albany NY); 2021 Apr; 13(8):10934-10954. PubMed ID: 33847600
[TBL] [Abstract][Full Text] [Related]
14. Short-chain fatty acids affect the development of inflammatory bowel disease through intestinal barrier, immunology, and microbiota: A promising therapy?
Peng K; Xia S; Xiao S; Yu Q
J Gastroenterol Hepatol; 2022 Sep; 37(9):1710-1718. PubMed ID: 35906780
[TBL] [Abstract][Full Text] [Related]
15. Review: Effect of Gut Microbiota and Its Metabolite SCFAs on Radiation-Induced Intestinal Injury.
Li Y; Zhang Y; Wei K; He J; Ding N; Hua J; Zhou T; Niu F; Zhou G; Shi T; Zhang L; Liu Y
Front Cell Infect Microbiol; 2021; 11():577236. PubMed ID: 34307184
[TBL] [Abstract][Full Text] [Related]
16. From gut microbiota dysfunction to obesity: could short-chain fatty acids stop this dangerous course?
Barrea L; Muscogiuri G; Annunziata G; Laudisio D; Pugliese G; Salzano C; Colao A; Savastano S
Hormones (Athens); 2019 Sep; 18(3):245-250. PubMed ID: 30840230
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota-derived short-chain fatty acids and kidney diseases.
Li L; Ma L; Fu P
Drug Des Devel Ther; 2017; 11():3531-3542. PubMed ID: 29270002
[TBL] [Abstract][Full Text] [Related]
18. Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis.
Portincasa P; Bonfrate L; Vacca M; De Angelis M; Farella I; Lanza E; Khalil M; Wang DQ; Sperandio M; Di Ciaula A
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163038
[TBL] [Abstract][Full Text] [Related]
19. From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites.
Koh A; De Vadder F; Kovatcheva-Datchary P; Bäckhed F
Cell; 2016 Jun; 165(6):1332-1345. PubMed ID: 27259147
[TBL] [Abstract][Full Text] [Related]
20. The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication.
Silva YP; Bernardi A; Frozza RL
Front Endocrinol (Lausanne); 2020; 11():25. PubMed ID: 32082260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
